Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience

R hajjeh, L Privor-Dumm, Karen Edmond, Rosalyn O'Loughlin, Sharmila Shetty, Ulla K Griffiths, A P Bear, Adam Cohen, A Chandran, A Schuchat, Edward (Kim) MULHOLLAND, M Santosham

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.
    Original languageEnglish
    Pages (from-to)7123-7129
    Number of pages7
    JournalVaccine
    Volume28
    Issue number43
    DOIs
    Publication statusPublished - 8 Oct 2010

    Fingerprint

    Dive into the research topics of 'Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience'. Together they form a unique fingerprint.

    Cite this